 Lymphoma, Non-Hodgkin
"Lymphoma, Non-Hodgkin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Descriptor ID |
D008228
|
| MeSH Number(s) |
C04.557.386.480 C15.604.515.569.480 C20.683.515.761.480
|
| Concept/Terms |
Lymphoma, Non-Hodgkin- Lymphoma, Non-Hodgkin
- Lymphoma, Non Hodgkin
- Lymphoma, Atypical Diffuse Small Lymphoid
- Lymphoma, Non-Hodgkin's
- Lymphoma, Non Hodgkin's
- Lymphoma, Non-Hodgkins
- Lymphoma, Non Hodgkins
- Non-Hodgkins Lymphoma
- Small Cleaved-Cell Lymphoma, Diffuse
- Small Cleaved Cell Lymphoma, Diffuse
- Lymphoma, Nonhodgkins
- Nonhodgkins Lymphoma
- Lymphoma, Small Cleaved Cell, Diffuse
- Lymphoma, Small Cleaved-Cell, Diffuse
- Non-Hodgkin Lymphoma
- Non Hodgkin Lymphoma
- Non-Hodgkin's Lymphoma
- Non Hodgkin's Lymphoma
- Diffuse Small Cleaved-Cell Lymphoma
- Diffuse Small Cleaved Cell Lymphoma
- Lymphoma, Nonhodgkin's
- Lymphoma, Nonhodgkin
- Nonhodgkin's Lymphoma
Lymphoma, High-Grade- Lymphoma, High-Grade
- High-Grade Lymphoma
- High-Grade Lymphomas
- Lymphoma, High Grade
- Lymphomas, High-Grade
Lymphoma, Intermediate-Grade- Lymphoma, Intermediate-Grade
- Intermediate-Grade Lymphoma
- Intermediate-Grade Lymphomas
- Lymphoma, Intermediate Grade
- Lymphomas, Intermediate-Grade
Reticulum-Cell Sarcoma- Reticulum-Cell Sarcoma
- Reticulum Cell Sarcoma
- Reticulum-Cell Sarcomas
- Sarcomas, Reticulum-Cell
- Sarcoma, Reticulum-Cell
- Sarcoma, Reticulum Cell
- Reticulosarcoma
- Reticulosarcomas
Lymphoma, Mixed-Cell- Lymphoma, Mixed-Cell
- Lymphoma, Mixed Cell
- Lymphoma, Mixed Lymphocytic-Histiocytic
- Lymphocytic-Histiocytic Lymphoma, Mixed
- Lymphocytic-Histiocytic Lymphomas, Mixed
- Lymphoma, Mixed Lymphocytic Histiocytic
- Lymphomas, Mixed Lymphocytic-Histiocytic
- Mixed Lymphocytic-Histiocytic Lymphoma
- Mixed Lymphocytic-Histiocytic Lymphomas
- Mixed-Cell Lymphoma
- Lymphomas, Mixed-Cell
- Mixed Cell Lymphoma
- Mixed-Cell Lymphomas
- Lymphoma, Mixed
- Lymphomas, Mixed
- Mixed Lymphoma
- Mixed Lymphomas
Lymphoma, Mixed-Cell, Diffuse- Lymphoma, Mixed-Cell, Diffuse
- Diffuse Mixed Small and Large Cell Lymphoma
- Diffuse Mixed-Cell Lymphoma
- Diffuse Mixed Cell Lymphoma
- Diffuse Mixed-Cell Lymphomas
- Lymphoma, Diffuse Mixed-Cell
- Lymphomas, Diffuse Mixed-Cell
- Mixed-Cell Lymphomas, Diffuse
- Mixed-Cell Lymphoma, Diffuse
- Mixed Cell Lymphoma, Diffuse
- Lymphoma, Mixed Cell, Diffuse
- Lymphoma, Small and Large Cleaved-Cell, Diffuse
- Mixed Small and Large Cell Lymphoma, Diffuse
- Lymphoma, Mixed Small and Large Cell, Diffuse
- Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic
Lymphoma, Small Noncleaved-Cell- Lymphoma, Small Noncleaved-Cell
- Lymphoma, Small Noncleaved Cell
- Diffuse Undifferentiated Lymphoma
- Diffuse Undifferentiated Lymphomas
- Lymphoma, Diffuse Undifferentiated
- Lymphomas, Diffuse Undifferentiated
- Undifferentiated Lymphoma, Diffuse
- Undifferentiated Lymphomas, Diffuse
- Lymphoma, Undifferentiated, Diffuse
- Small Non-Cleaved-Cell Lymphoma
- Small Non Cleaved Cell Lymphoma
- Small Noncleaved-Cell Lymphoma
- Lymphomas, Small Noncleaved-Cell
- Noncleaved-Cell Lymphoma, Small
- Noncleaved-Cell Lymphomas, Small
- Small Noncleaved Cell Lymphoma
- Small Noncleaved-Cell Lymphomas
- Lymphoma, Small Non-Cleaved-Cell
- Lymphoma, Small Non Cleaved Cell
- Lymphomas, Small Non-Cleaved-Cell
- Non-Cleaved-Cell Lymphoma, Small
- Non-Cleaved-Cell Lymphomas, Small
- Small Non-Cleaved-Cell Lymphomas
Lymphoma, Undifferentiated- Lymphoma, Undifferentiated
- Undifferentiated Lymphoma
- Lymphomas, Undifferentiated
- Undifferentiated Lymphomas
- Lymphoma, Pleomorphic
- Lymphomas, Pleomorphic
- Pleomorphic Lymphoma
- Pleomorphic Lymphomas
Lymphoma, Diffuse- Lymphoma, Diffuse
- Diffuse Lymphoma
- Diffuse Lymphomas
- Lymphomas, Diffuse
- Lymphosarcoma
- Lymphosarcomas
- Sarcoma, Lymphatic
- Lymphatic Sarcoma
- Lymphatic Sarcomas
- Sarcomas, Lymphatic
Lymphoma, Low-Grade- Lymphoma, Low-Grade
- Low-Grade Lymphoma
- Low-Grade Lymphomas
- Lymphoma, Low Grade
- Lymphomas, Low-Grade
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Non-Hodgkin".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Non-Hodgkin".
This graph shows the total number of publications written about "Lymphoma, Non-Hodgkin" by people in this website by year, and whether "Lymphoma, Non-Hodgkin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1987 | 2 | 0 | 2 | | 1988 | 2 | 1 | 3 | | 1989 | 2 | 1 | 3 | | 1990 | 6 | 0 | 6 | | 1991 | 1 | 0 | 1 | | 1992 | 2 | 0 | 2 | | 1993 | 3 | 2 | 5 | | 1994 | 2 | 0 | 2 | | 1995 | 4 | 0 | 4 | | 1996 | 5 | 2 | 7 | | 1997 | 10 | 0 | 10 | | 1998 | 8 | 0 | 8 | | 1999 | 4 | 2 | 6 | | 2000 | 4 | 2 | 6 | | 2001 | 4 | 0 | 4 | | 2002 | 6 | 0 | 6 | | 2003 | 4 | 0 | 4 | | 2004 | 4 | 1 | 5 | | 2005 | 6 | 1 | 7 | | 2006 | 9 | 1 | 10 | | 2007 | 7 | 1 | 8 | | 2008 | 9 | 1 | 10 | | 2009 | 7 | 0 | 7 | | 2010 | 8 | 3 | 11 | | 2011 | 6 | 3 | 9 | | 2012 | 13 | 0 | 13 | | 2013 | 6 | 0 | 6 | | 2014 | 4 | 0 | 4 | | 2015 | 5 | 1 | 6 | | 2018 | 6 | 0 | 6 | | 2019 | 3 | 0 | 3 | | 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphoma, Non-Hodgkin" by people in Profiles.
-
van Besien K, Orfali N, Shore T. Allogeneic Transplant Conditioning Regimens for Patients With Non-Hodgkin Lymphoma. JAMA Oncol. 2020 12 01; 6(12):1983-1984.
-
Yuen CA, Mastrianni J, Ali S, Pytel P, Park DM, Rezania K. An atypical presentation of primary central nervous system lymphoma: A case report. Medicine (Baltimore). 2020 Sep 18; 99(38):e22062.
-
van Besien KW, Orfali N. Alternative Donor Transplantation for Lymphoid Malignancies: How Far We Have Come. J Clin Oncol. 2020 05 10; 38(14):1501-1504.
-
Van Slambrouck C, Huh J, Suh C, Song JY, Menon MP, Sohani AR, Duffield AS, Goldberg RC, Dama P, Kiyotani K, Godfrey J, Fitzpatrick C, Kline J, Smith SM, Jaffe ES, Hartmann S, Venkataraman G. Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities. Mod Pathol. 2020 05; 33(5):834-845.
-
Cerhan JR, Kane E, Vajdic CM, Linet MS, Monnereau A, Bernstein L, de Sanjose S, Chiu BC, Spinelli JJ, Maso LD, Zhang Y, Larrabee BR, Cozen W, Smith AG, Clavel J, Serraino D, Zheng T, Holly EA, Weisenberger DD, Slager SL, Bracci PM. Blood transfusion history and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis. Cancer Causes Control. 2019 Aug; 30(8):889-900.
-
Mukhija D, Nagpal SJS, Sohal DPS. Epidemiology, Tumor Characteristics, and Survival in Patients With Primary Pancreatic Lymphoma: A Large Population-based Study Using the SEER Database. Am J Clin Oncol. 2019 05; 42(5):454-458.
-
Calip GS, Moran KM, Sweiss KI, Patel PR, Wu Z, Adimadhyam S, Lee TA, Ko NY, Quigley JG, Chiu BC. Myelodysplastic syndrome and acute myeloid leukemia after receipt of granulocyte colony-stimulating factors in older patients with non-Hodgkin lymphoma. Cancer. 2019 04 01; 125(7):1143-1154.
-
Coffey GP, Feng J, Betz A, Pandey A, Birrell M, Leeds JM, Der K, Kadri S, Lu P, Segal J, Wang YL, Michelson G, Curnutte JT, Conley PB. Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clin Cancer Res. 2019 02 15; 25(4):1174-1184.
-
Siegel SE, Advani A, Seibel N, Muffly L, Stock W, Luger S, Shah B, DeAngelo DJ, Freyer DR, Douer D, Johnson RH, Hayes-Lattin B, Lewis M, Jaboin JJ, Coccia PF, Bleyer A. Treatment of young adults with Philadelphia-negative acute lymphoblastic leukemia and lymphoblastic lymphoma: Hyper-CVAD vs. pediatric-inspired regimens. Am J Hematol. 2018 10; 93(10):1254-1266.
-
de Vos S, Swinnen LJ, Wang D, Reid E, Fowler N, Cordero J, Dunbar M, Enschede SH, Nolan C, Petrich AM, Ross JA, Salem AH, Verdugo M, Agarwal S, Zhou L, Kozloff M, Nastoupil LJ, Flowers CR. Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. Ann Oncol. 2018 09 01; 29(9):1932-1938.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|